drugset / Trial / NCT02644629
Intra-nasal vs. Intra-venous Ketamine Administration
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The current study wishes to contribute to the applicability of the use of ketamine in a clinical setting by focusing on the efficacy of intra-nasal administration compared with the IV route.
Timeline
- Start
- 2016-04
- Primary completion
- 2020-05
- Completion
- 2020-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | 0.2 mg/kg | Intravenous |
| Comparator | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |
| Comparator | Ketamine | Small molecule | 50 mg | Intravenous |